We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $618B
1-Year Est. Return 30.34%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+7.8%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$484B
AUM Growth
+$29.1B
Cap. Flow
-$16.6B
Cap. Flow %
-3.43%
Top 10 Hldgs %
36.47%
Holding
15,826
New
1,205
Increased
5,575
Reduced
7,223
Closed
1,563

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$545M
2
DXCM icon
DexCom
DXCM
+$457M
3
T icon
AT&T
T
+$431M
4
PANW icon
Palo Alto Networks
PANW
+$416M
5
HUM icon
Humana
HUM
+$394M

Sector Composition

Rank Sector Weight
1 Technology 3.01%
2 Healthcare 2.92%
3 Consumer Discretionary 1.99%
4 Financials 1.93%
5 Industrials 1.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VJET
15426
DELISTED
VOXELJET AG American Depositary Shares (each representing one Ordinary Share)
VJET
-13,220
Closed -$27.1K
ADOCR
15427
DELISTED
Edoc Acquisition Corp. Right
ADOCR
-12,117
Closed -$2.33K
BCEL
15428
PUT
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
-600
Closed -$684
BKCC
15429
CALL
DELISTED
BlackRock Capital Investment Corporation
BKCC
-4,300
Closed -$14.8K
BTTX
15430
CALL
DELISTED
Better Therapeutics, Inc. Common Stock
BTTX
-48,300
Closed -$35.2K
BTTX
15431
PUT
DELISTED
Better Therapeutics, Inc. Common Stock
BTTX
-100
Closed -$73
ESCR
15432
DELISTED
Xtrackers Bloomberg US Investment Grade Corporate ESG ETF
ESCR
-14,126
Closed -$261K
CURO
15433
CALL
DELISTED
CURO Group Holdings Corp.
CURO
-4,600
Closed -$7.96K
CURO
15434
DELISTED
CURO Group Holdings Corp.
CURO
-8,563
Closed -$14.8K
CURO
15435
PUT
DELISTED
CURO Group Holdings Corp.
CURO
-2,000
Closed -$3.46K
PHXM
15436
PUT
DELISTED
PHAXIAM Therapeutics S.A.. American Depositary Shares
PHXM
-10
Closed -$98
ACAH
15437
DELISTED
Atlantic Coastal Acquisition Corp. Class A Common Stock
ACAH
-11,002
Closed -$111K
BPTH
15438
DELISTED
Bio-Path Holdings Inc
BPTH
-1,773
Closed -$49.3K
THCX
15439
CALL
DELISTED
AXS Cannabis ETF
THCX
-180
Closed -$3.87K
THCX
15440
DELISTED
AXS Cannabis ETF
THCX
-1,178
Closed -$25.3K
THCX
15441
PUT
DELISTED
AXS Cannabis ETF
THCX
-220
Closed -$4.73K
SIEN
15442
DELISTED
Sientra, Inc.
SIEN
-1,066
Closed -$1.9K
FRLN
15443
DELISTED
Freeline Therapeutics Holdings plc American Depositary Shares
FRLN
-7,786
Closed -$53.7K
MARK
15444
CALL
DELISTED
Remark Holdings, Inc.
MARK
-6,000
Closed -$8.22K
MARK
15445
PUT
DELISTED
Remark Holdings, Inc.
MARK
-9,200
Closed -$12.6K
ALYA
15446
DELISTED
Alithya Group Inc Class A Subordinate Voting Shares
ALYA
-11,719
Closed -$23.3K
DMK
15447
CALL
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
-213
Closed -$1.73K
DMK
15448
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
-4,674
Closed -$37.9K
DMK
15449
PUT
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
-60
Closed -$487
WTER
15450
DELISTED
The Alkaline Water Company Inc. Common Stock
WTER
-2,376
Closed -$5.71K

Similar funds

Ken Griffin's Q2 2023 Portfolio in Review

As of Q2 2023, Ken Griffin held 15,826 positions worth $484B, up 6.4% from $455B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Ken Griffin withdrew a net $16.6B in Q2 2023, closing 1,563 positions and reducing 7,223 holdings. Its most notable exit was State Street Industrial Select Sector SPDR ETF, an estimated $192M position sold in full.

By sector, the portfolio is most concentrated in Technology at 3% of assets, down from 3.2% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Ken Griffin opened a new position in BILL Holdings worth $222M.

  • Ken Griffin's largest Q2 2023 buy was BILL Holdings: 1,901,064 shares worth $222M.
  • Ken Griffin added most to Microsoft in Q2 2023, an estimated $640M increase.
  • Ken Griffin's biggest Q2 2023 reduction was NVIDIA, cutting an estimated $545M.
  • Ken Griffin fully exited State Street Industrial Select Sector SPDR ETF in Q2 2023, selling an estimated $192M.
  • Ken Griffin's ten largest holdings make up 36% of its $484B portfolio in Q2 2023.
  • Ken Griffin opened 1,205 new positions and closed 1,563 in Q2 2023.
  • Ken Griffin's portfolio value rose 6.4% quarter-over-quarter to $484B.

Based on Citadel Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.